SK3782003A3 - Sodium salts of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione - Google Patents

Sodium salts of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione Download PDF

Info

Publication number
SK3782003A3
SK3782003A3 SK378-2003A SK3782003A SK3782003A3 SK 3782003 A3 SK3782003 A3 SK 3782003A3 SK 3782003 A SK3782003 A SK 3782003A SK 3782003 A3 SK3782003 A3 SK 3782003A3
Authority
SK
Slovakia
Prior art keywords
sodium salt
pyridyl
dione
methyl
amino
Prior art date
Application number
SK378-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK3782003A3 publication Critical patent/SK3782003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK378-2003A 2000-09-29 2001-09-28 Sodium salts of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione SK3782003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023971.5A GB0023971D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004334 WO2002026735A1 (fr) 2000-09-29 2001-09-28 Sels de sodium de 5-'4-'2-(n-methyl-n-(2-pyridyl)amino) ethoxy!benzyl!thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
SK3782003A3 true SK3782003A3 (en) 2004-06-08

Family

ID=9900428

Family Applications (1)

Application Number Title Priority Date Filing Date
SK378-2003A SK3782003A3 (en) 2000-09-29 2001-09-28 Sodium salts of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Country Status (27)

Country Link
US (4) US20040014752A1 (fr)
EP (2) EP1813612A1 (fr)
JP (1) JP2004509959A (fr)
KR (1) KR100917953B1 (fr)
CN (4) CN101125853A (fr)
AP (1) AP1738A (fr)
AU (2) AU9202801A (fr)
BG (1) BG107679A (fr)
BR (1) BR0114308A (fr)
CA (1) CA2423975A1 (fr)
CZ (1) CZ302181B6 (fr)
DZ (1) DZ3480A1 (fr)
EA (1) EA005109B1 (fr)
EC (1) ECSP034528A (fr)
GB (1) GB0023971D0 (fr)
HU (1) HUP0301188A3 (fr)
IL (2) IL155051A0 (fr)
MA (1) MA25912A1 (fr)
MX (1) MXPA03002868A (fr)
NO (2) NO20031435L (fr)
NZ (1) NZ524933A (fr)
OA (1) OA12399A (fr)
PL (1) PL363701A1 (fr)
SK (1) SK3782003A3 (fr)
UA (1) UA74842C2 (fr)
WO (1) WO2002026735A1 (fr)
ZA (1) ZA200302439B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8133637B2 (en) * 2005-10-06 2012-03-13 Headwaters Technology Innovation, Llc Fuel cells and fuel cell catalysts incorporating a nanoring support
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2011075514A1 (fr) * 2009-12-15 2011-06-23 Metabolic Solutions Development Company Thiazolidinediones épargnant les ppar et associations pour le traitement de maladies neurodégénératives

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (fr) * 1987-09-04 1999-11-17 Beecham Group Plc Thiazolidinediones substituées
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1253236A (zh) * 1998-11-11 2000-05-17 李扬远 一种以重力差释放引力能的方法
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
NZ524933A (en) 2004-12-24
EP1332142A1 (fr) 2003-08-06
EA200300422A1 (ru) 2003-08-28
CN1466585A (zh) 2004-01-07
EP1813612A1 (fr) 2007-08-01
KR20030039377A (ko) 2003-05-17
NO20031435D0 (no) 2003-03-28
HUP0301188A2 (hu) 2003-11-28
US20040014752A1 (en) 2004-01-22
NO20076517L (no) 2003-04-29
CZ302181B6 (cs) 2010-12-01
MXPA03002868A (es) 2004-12-06
CN1915992A (zh) 2007-02-21
PL363701A1 (en) 2004-11-29
CZ2003850A3 (cs) 2004-03-17
EA005109B1 (ru) 2004-10-28
CN1915992B (zh) 2010-05-12
GB0023971D0 (en) 2000-11-15
AP2003002767A0 (en) 2003-03-31
AU2001292028B2 (en) 2005-04-21
AU9202801A (en) 2002-04-08
HUP0301188A3 (en) 2005-04-28
ZA200302439B (en) 2004-04-28
KR100917953B1 (ko) 2009-09-21
BR0114308A (pt) 2003-10-14
MA25912A1 (fr) 2003-10-01
CA2423975A1 (fr) 2002-04-04
US20060004058A1 (en) 2006-01-05
UA74842C2 (en) 2006-02-15
BG107679A (bg) 2003-12-31
AP1738A (en) 2007-05-07
US20040214866A1 (en) 2004-10-28
CN101125852A (zh) 2008-02-20
OA12399A (en) 2004-09-06
ECSP034528A (es) 2003-05-26
IL155051A0 (en) 2003-10-31
IL188116A0 (en) 2008-03-20
CN101125853A (zh) 2008-02-20
JP2004509959A (ja) 2004-04-02
US20070185167A1 (en) 2007-08-09
DZ3480A1 (fr) 2002-04-04
CN100345846C (zh) 2007-10-31
US20050277679A9 (en) 2005-12-15
WO2002026735A1 (fr) 2002-04-04
NO20031435L (no) 2003-05-27

Similar Documents

Publication Publication Date Title
KR100744359B1 (ko) 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
BG65485B1 (bg) Тиазолидиндионово производно, метод за получаването му, фармацевтичен състав и използването му в медицината
HRP20000408A2 (en) 5-(4-(2-(n-metyl-n-(2-pyridyl)amino)ethoxy(benzyl(thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
BG65517B1 (bg) Тиазолидиндионово производно и неговото използване като антидиабетично средство
SK3782003A3 (en) Sodium salts of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK2632003A3 (en) The hydrochloride salt of 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK1442003A3 (en) Tartrate salts of thiazolidinedione derivative
EP1305311B1 (fr) Tartrate de derive de thiazolidinedione
SK3792003A3 (en) A thiazolidinedione derivative and its use as antidiabetic
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
WO2003050113A1 (fr) Sel d'hydrogene sulfate de 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
SK17152002A3 (sk) Hydrojodid 5-[4-[2-(N-metyl-N-(2-pyridyl)amíno)etoxy]- benzyl]tiazolidín-2,4-diónu ako liečivo
AU2001292028A1 (en) Sodium salts of 5-'4-'2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione
SK287243B6 (sk) Soľ 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoxy]benzyl]thiazolidín- 2,4-diónu a kyseliny L (+) vínnej, spôsob jej prípravy a použitie, farmaceutická kompozícia s jej obsahom
WO2003050112A1 (fr) Hydrates de toluenesulfonate d'un derive de thiazolidinedione

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure